PROST Study for Occlusive Stroke Treatment
Protocol: SITE00000118
Full Title
pRESET for Occlusive Stroke Treatment
Description
This study enrolls adults who are hospitalized for acute ischemic stroke. The purpose of this study is to learn how safe and effective the pRESET Thrombectomy Device is for the treatment of this condition and for removing the blood clot.

You will be in this study for about 3 months after you have your procedure. During the procedure, either the pRESET or the market approved Solitaire device will be used to treat your blood clot. You will be randomized (like the flip of a coin) to have one of the two devices. After your procedure, you will have 2 study visits in-person and others by phone. Study takes place at BUffalo General Hospital and gates Vascular Institute (875 Ellicott St. Buffalo, NY 14203).

Technical Description

To determine the safety and effectiveness of pRESET for the treatment of acute ischemic stroke within 8
hours of symptom onset (defined as time patient was last seen well) due to large vessel occlusion and to
compare safety and effectiveness to the predicate device, Solitaire??? Platinum revascularization device
(Medtronic).
Compensation: No
Eligibility
Adults ages 18+.
Currently admitted to the hospital for an acute ischemic stroke that began in the last 8 hours.
Age Group: Adults
ClinicalTrials.gov: Open Study
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.
Thank you for your interest. This study has restricted recruiting for participants and is not accepting inquiries at this time. If you are interested in learning more about research at UB contact ctsiresearch@buffalo.edu.